ClinicalTrials.Veeva

Menu

VRQOL in Cataract Patients During the COVID-19 Pandemic

M

Medical University Innsbruck

Status

Unknown

Conditions

Senile Cataract

Treatments

Other: Questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT04468308
VRQOL Cataract COVID-19

Details and patient eligibility

About

The aim of this questionnaire survey is to evaluate the improvement in vision-related quality of life before and after cataract surgery using the National Eye Institute Visual Function Questionnaire 25 and the delay of improvement in the COVID-19 pandemic.

Enrollment

116 estimated patients

Sex

All

Ages

50+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥ 50 years
  • Senile cataract
  • Indication for unilateral or bilateral cataract surgery
  • Postponed cataract surgery due to the COVID-19 pandemic
  • Signed and dated declaration of consent

Exclusion criteria

  • Complex form of cataract (traumatic cataract, secondary cataract after intraocular inflammation)
  • Amblyopia on the eye that is to be operated on
  • Severe, visually impairing eye disease on the eye that is to operated on
  • Known dementia or memory problems

Trial design

116 participants in 1 patient group

Senile Cataract
Description:
Patient with senile cataract, whose cataract surgery was postponed in the COVID-19 pandemic
Treatment:
Other: Questionnaire

Trial contacts and locations

1

Loading...

Central trial contact

Claus Zehetner, Dr.; Teresa Rauchegger, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems